TherapySelect presents the CTR-Test® on the "Day of Integrative Cancer Medicine" (06.07.) in the Emil-Schlegel Clinic (Rottenburg, Germany)

Dr. Frank Kischkel was invited by Emil-Schlegel-Klink to give a presentation on the "Day of Integrative Cancer Medicine" (06.07.). Interested patients as well as people from the medical field attended the event. Presentation on the "Day of Integrative Cancer Medicine"...

TherapySelect presents the CTR-Test® at the PerMediCon conference (05.-06.03.) in Cologne especially for the pharmaceutical industry

As in 2012 TherapySelect attends a important conference concerning personalized medicine for information exchange about new developments. TherapySelect uses the opportunity to present the CTR-Test ® . The focus was put on the utilization of the CTR-Test ® for pharmaceutical industry for improving...

KPS and Dr. Frank Kischkel jointly present the Oncompass™ Service at the international ESMO conference (28.09.-02.10.) in Vienna (Austria)

<>Dr. Frank Kischkel is in negotiation with KPS for a cooperation to offer the Oncompass™ Service in Germany. The official cooperation is initiated with the join presentation from KPS and Dr. Frank Kischkel at the conference of the European Society for Medical Oncology (ESMO) which takes...

TherapySelect presents the CTR-Test® at the PerMediCon conference (19.-20.06.) in Cologne especially for the pharmaceutical industry

The PerMediCon is the most important conference for personalized medicine within Europe. Dr. Frank Kischkel was invited to present the CTR-Test ® especially for the pharmaceutical industry. Therefore Dr. Kischkel gave a presentation about the utilization of the CTR-Test ® for the improvement of...

TherapySelect still offers training courses for physicians in the field of in vitro cancer diagnostics for free

<>Due to the vivid request, TherapySelect will provide further training courses for clinics and specialized departments in the field of functional cancer diagnostics (focus on sensitivity testing for chemotherapeutic agents) in future. The events usually consist of a scientific lecture and a...

Extreme Drug Resistance Assay (EDR-Test) becomes Chemotherapy- Resistence-Test (CTR-Test®) - Information about the change of the name

Since this year's opening of the European reference laboratory in Heidelberg all of the services of the TherapySelect GmbH & Co. KG are performed in Germany. In terms of this change the name could also be adjusted to the German market. Therefore we chose CTR-Test ® (Chemotherapy-Resistance-Test...

CTR-Test® received NUB status 1 from the Institution for Hospital Remuneration System (InER GmbH)

As in the past years, the Chemotherapy-Resistance-Test (CTR ® -Test) received NUB (new examination and treatment methods) status 1 from the Institution for the Hospital Remuneration System (InEK GmbH). This entitles the clinics, which submitted a NUB request for the EDR ® -Test, to arrange a...